KDT, INC
Biotech · Private
RecombiRED, a fluorescent reagent for microinjection into embryos to detect homologous recombination repair and identify successful genome editing events
- Grants
- $1.7M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 2 granted · 0 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · A fluorescent reporter detecting precise homologous recombination transgenesis activity | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A fluorescent reporter detecting precise homologous recombination transgenesis activity | $747,005 | |
| Federal grant | Department of Health and Human Services · Phase II · A fluorescent reporter detecting precise homologous recombination transgenesis activity | $752,994 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1397 | Granite Bio | — | — |
| 1398 | Emalex Biosciences | — | — |
| 1399 | Chemomab | — | — |
| 1400 | KDT, INC | — | — |
| 1401 | HOUSTON PHARMECUTICAL INC | — | — |
| 1402 | MYOFINITY BIOSCIENCES INC | — | — |
| 1403 | PANACISE BIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Transgenic Biosensorgranted
- Transgenic BioSensorgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.